ACADIAN ASSET MANAGEMENT LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$109
-100.0%
3,073
-84.9%
0.00%
-100.0%
Q3 2022$898,000
+739.3%
20,390
+757.4%
0.01%
Q1 2021$107,000
-94.5%
2,378
-93.1%
0.00%
-100.0%
Q4 2020$1,946,000
+63.0%
34,404
+36.8%
0.01%
+60.0%
Q3 2020$1,194,000
-65.4%
25,157
-57.0%
0.01%
-66.7%
Q2 2020$3,452,000
+6538.5%
58,523
+5205.8%
0.02%
Q1 2020$52,000
-71.4%
1,103
-63.4%
0.00%
-100.0%
Q4 2019$182,000
+193.5%
3,010
+212.6%
0.00%
Q2 2019$62,000
-18.4%
963
+2.6%
0.00%
Q1 2019$76,000
-63.3%
939
-75.5%
0.00%
-100.0%
Q4 2018$207,000
+2487.5%
3,828
+2322.8%
0.00%
Q3 2018$8,000
+14.3%
1580.0%0.00%
Q2 2018$7,000
+250.0%
158
+229.2%
0.00%
Q1 2018$2,000
-98.6%
48
-98.3%
0.00%
-100.0%
Q4 2017$143,000
-16.4%
2,829
-16.3%
0.00%0.0%
Q3 2017$171,000
+2750.0%
3,380
+2263.6%
0.00%
Q1 2017$6,000
-25.0%
143
+6.7%
0.00%
Q4 2015$8,0001340.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders